Acid Reflux News and Information
July 10th 2010
Extremely obese children have a 40 percent higher risk of gastroesophageal reflux disease (GERD) and children who are moderately obese have a 30 percent higher risk of GERD compared to normal weight children, according to a Kaiser Permanente study published online in the International Journal of Pediatric Obesity…
July 9th 2010
A large US study found that compared to normal weight children, obese children have a higher risk of developing gastroesophageal reflux disease (GERD), a condition where stomach fluid flows up into the food pipe or esophagus, damaging the lining and possibly also raising the incidence of inflammation, asthma and coughs…
June 8th 2010
Molecular imaging has uncovered what may be to blame for acid reflux disease, a painful and potentially dangerous illness that affects a sizeable percentage of the population…
June 4th 2010
Eisai Inc. (Headquarters: Woodcliff Lake, NJ; Chairman and CEO: Hajime Shimizu), a U.S. subsidiary of Eisai Co., Ltd. (Headquarters: Tokyo; President and CEO: Haruo Naito) announced that the U.S…
June 1st 2010
The Food and Drug Administration (FDA), USA has denied approval of AstraZeneca’s Axanum (aspirin plus esomeprazole magnesium) and an expanded indication for AstraZeneca’s Nexium (esomeprazole magnesium). AstraZeneca received a CRL (Complete Response Letter) for the new drug application for Axanum tablets, as well as a CRL for the supplemental new drug application (sNDA) for Nexium…
May 26th 2010
The US Food and Drug Administration (FDA) has warned that high dose, long term use of a class of drugs known as Proton Pump Inhibitors (PPIs), for conditions such as heartburn, acid reflux and gastric ulcers, carries an increased risk of bone fractures in the wrist, hip and spine…
May 21st 2010
Gastroesophageal reflux (GER), defined as passage of gastric contents into the esophagus is a normal process that occurs in healthy infants, children and adults. When GER causes troublesome symptoms and/or complications it is referred to as gastroesophageal reflux disease (GERD)…
May 6th 2010
Merck Consumer Care has announced results of a head-to-head clinical study showing that ZEGERID OTC™ offers greater and faster acid control than Prevacid® 24HR. While acid control is an industry standard measure for acid-reducing drugs, greater and faster acid control does not imply greater and faster heartburn symptom relief…
May 6th 2010
Merck Consumer Care has announced results of a head-to-head clinical study showing that ZEGERID OTC™ offers greater and faster acid control than Prevacid® 24HR. While acid control is an industry standard measure for acid-reducing drugs, greater and faster acid control does not imply greater and faster heartburn symptom relief…
May 5th 2010
Gastroesophageal reflux disease (GERD) is a debilitating problem for sufferers — heartburn, difficulty swallowing, chest pain and acid reflux…
May 5th 2010
A pathology test may help doctors distinguish between two separate but overlapping esophageal disorders that require different courses of treatment, according to a study by researchers at the University of North Carolina at Chapel Hill…
April 27th 2010
Takeda Pharmaceuticals North America, Inc. today announced that DEXILANT™ (dexlansoprazole) delayed release capsules are now available in United States (U.S.) pharmacies. Takeda recently announced that the product trade name for dexlansoprazole in the U.S. would be changed from KAPIDEX™ to DEXILANT…
April 21st 2010
The growing number of Americans with cardiovascular disease has caused a heightened sensitivity in the evaluation of chest pain…
April 14th 2010
Cancer of the lower esophagus develops almost exclusively in patients with Barrett’s esophagus, an otherwise benign complication of esophageal reflux that affects approximately 3 million Americans. Although the prognosis of patients diagnosed with esophageal cancer is poor, the chances of successful treatment increase significantly if the disease is detected at an early dysplastic stage…
April 9th 2010
Torax Medical Inc., a medical device company focused on the minimally invasive treatment of gastro-esophageal reflux disease (GERD), has received CE Mark for its LINX® Anti-Reflux treatment.. The company has started commercial launch of the LINX device at select centers in Europe…
April 2nd 2010
Gastroesophageal reflux disorder (GERD) and irritable bowel syndrome (IBS) are two very common disorders affecting the gastrointestinal tract. About 10% of the population experience daily discomfort from reflux of gastric contents into the esophagus. More than 10% of the population experience abdominal pain and disturbed bowel movement because of irritable bowel syndrome…
March 31st 2010
Gastroesophageal reflux disease (GERD) is an important public health problem which is extremely common nowadays. Symptoms of GERD arise from the exposure of increased acid gastric contents into the lower part of the esophageal mucosa. Most patients with GERD have NERD with invisible mucosal damages under endoscopy…
March 23rd 2010
With stomach irritation preventing almost 2 out of every 10 people from enjoying coffee, scientists reported discovery of several substances that may be among the culprits responsible for brewing up heartburn and stomach pain in every cup…
March 17th 2010
Stomach wrap operations may be more effective than acid suppression tablets in the treatment of severe acid reflux, according to a new Cochrane Systematic Review. The study shows a more pronounced improvement in symptoms shortly after surgery than with drug treatment…
March 8th 2010
Nifedipine, a calcium-channel blocker, was shown to decrease lower esophageal sphincter pressure and increase esophageal acid exposure time, while atenolol, a b1 blocker, was shown to inhibit relaxation of the smooth muscle of the esophagus…